Article
Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers
29 Aug 2020
Abstract excerpt
PURPOSE: Despite extensive biological and clinical studies, including comprehensive genomic and transcriptomic profiling efforts, pancreatic ductal adenocarcinoma (PDAC) remains a devastating disease, with a poor survival and limited therapeutic options. The goal of this study was to assess co-expressed PDAC proteins and their associations with biological pathways and clinical parameters. METHODS: Correlation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
